Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H16ClN3O4S2 |
Molecular Weight | 353.845 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CC1NC2=CC(Cl)=C(C=C2S(=O)(=O)N1)S(N)(=O)=O
InChI
InChIKey=HGBFRHCDYZJRAO-UHFFFAOYSA-N
InChI=1S/C11H16ClN3O4S2/c1-6(2)3-11-14-8-4-7(12)9(20(13,16)17)5-10(8)21(18,19)15-11/h4-6,11,14-15H,3H2,1-2H3,(H2,13,16,17)
Molecular Formula | C11H16ClN3O4S2 |
Molecular Weight | 353.845 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Buthiazide (or Butizide) is a diuretic of the thiazide class. It was used for the treatment of mild to moderate essential hypertension. Buthiazide reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Ex vivo antigen preparation for the serological detection of drug-dependent antibodies in immune haemolytic anaemias. | 1984 Nov |
|
Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension. | 2009 |
|
Renal and vascular glutathione S-transferase mu is not affected by pharmacological intervention to reduce systolic blood pressure. | 2009 Aug |
|
Successful control of intractable hypoglycemia using rapamycin in an 86-year-old man with a pancreatic insulin-secreting islet cell tumor and metastases. | 2009 Sep |
|
[Chlorthalidone better than hydrochlorothiazide in hypertension]. | 2010 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6706271
The combination of 100 mg spironolactone either with 5 mg bendrofluazide or with 10 mg butizide increased significantly the diuresis over the whole day.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:07:01 GMT 2023
by
admin
on
Fri Dec 15 19:07:01 GMT 2023
|
Record UNII |
W00SSD35VW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QC03EA14
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
||
|
WHO-ATC |
C03EA14
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
446
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | |||
|
W00SSD35VW
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | |||
|
16274
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | |||
|
19882
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB06024MIG
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | |||
|
C171919
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | |||
|
C009732
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | |||
|
1410
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | |||
|
BUTIZIDE
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | |||
|
DTXSID6022713
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | |||
|
m2797
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000088634
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | |||
|
2043-38-1
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | |||
|
218-048-8
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104197
Created by
admin on Fri Dec 15 19:07:01 GMT 2023 , Edited by admin on Fri Dec 15 19:07:01 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |